The Almac Group is an international contract development and manufacturing organisation for the pharmaceutical and biotech industry. They provide a comprehensive range of integrated services ranging from:
- biomarker discovery and development
- API manufacture
- formulation development
- clinical trial supply
- IXRS technology(IVRS/IXRS)
- commercial-scale manufacture
- companion diagnostic development.
This privately owned organisation has its global headquarters in Northern Ireland and additional facilities in Scotland, England, US (Pennsylvania, North Carolina and California) and Asia (Singapore and Japan).
The company employs over 4000 staff worldwide and have in excess of 600 clients using their services, which is testament to the quality and innovation which Almac has demonstrated within the scientific sector over the last 30 years.